$19.04
0.341.82%
Benzinga
Benzinga
Benzinga
금요일, 10월 16
Benzinga
© 2026 Benzinga | All Rights Reserved
Tyra Biosciences (TYRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.65 | $-0.59 | $-0.53 | $-0.51 |
| Actual | $-0.69 | $-0.64 | $-0.57 | $-0.50 |
| Surprise | -6.15% | -8.47% | -7.55% | +1.96% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.66 | $-0.66 | $-0.60 | $-0.63 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.69 | $-0.65 | -6.15 % |
| Q1 | May 13, 2026 | $-0.64 | $-0.59 | -8.47 % |
| Q4 | Mar 2, 2026 | $-0.57 | $-0.53 | -7.55 % |
| Q3 | Nov 5, 2025 | $-0.50 | $-0.51 | 1.96 % |